United States · 
Who invested in Fuse Biotherapeutics?
Fuse Biotherapeutics's investors include Sherpa Healthcare Partners.
United States · Seed startup
Who invested in Fuse Biotherapeutics
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Fuse Biotherapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$9.5Mraised across 1 round since 2021, from 1 source
- Latest round
- Seed, $9.5MNov 2021
- Investors
- 1
The rounds
- Nov 2021
Founders and team
From the SEC filings it signed: 3 on the team.
- Brian RabinovichExecutive Officer, Directori
- Jeffrey TakimotoExecutive Officeri
- Paul SongExecutive Officer, Directori
On the board, as filediYuanheng Wang Liang
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Fuse Biotherapeutics
How much has Fuse Biotherapeutics raised?
Fuse Biotherapeutics has raised $9.5M across 1 round since 2021.
When did Fuse Biotherapeutics last raise?
Fuse Biotherapeutics's most recent round was a Seed of $9.5M in Nov 2021.
What was Fuse Biotherapeutics's biggest round?
Its most recent round, $9.5M in Nov 2021, is also its largest on record.
Who backed Fuse Biotherapeutics first?
Fuse Biotherapeutics's first round on record, in Nov 2021, was backed by Sherpa Healthcare Partners.
What stage is Fuse Biotherapeutics at?
Fuse Biotherapeutics's latest named round is a Seed, in Nov 2021.
Where is Fuse Biotherapeutics based?
Fuse Biotherapeutics is based in the United States.
Companies like Fuse Biotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.